GCP
SMED

GSA Capital Partners’s Sharps Compliance Corp SMED Stock Holding History

GSA Capital Partners’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-37,715
Closed -$269K – 1968
2021
Q4 		$269K Sell
37,715
-16,450
-30% -$126K 0.03% 1014
2021
Q3 		$448K Buy
+54,165
New +$504K 0.05% 760
2021
Q1 		– Sell
-17,827
Closed -$168K – 1625
2020
Q4 		$168K Buy
+17,827
New +$136K 0.03% 1029
2017
Q4 		– Sell
-28,858
Closed -$138K – 1899
2017
Q3 		$138K Sell
28,858
-36,344
-56% -$175K 0.01% 1494
2017
Q2 		$276K Sell
65,202
-21,198
-25% -$90.5K 0.02% 1327
2017
Q1 		$411K Sell
86,400
-1,249
-1% -$5.74K 0.02% 1206
2016
Q4 		$336K Sell
87,649
-13,677
-13% -$55.5K 0.02% 1266
2016
Q3 		$444K Sell
101,326
-8,095
-7% -$39.2K 0.02% 1126
2016
Q2 		$480K Hold
109,421
– – 0.03% 1103
2016
Q1 		$602K Buy
109,421
+9,600
+10% +$58.2K 0.04% 890
2015
Q4 		$868K Buy
99,821
+47,110
+89% +$408K 0.04% 801
2015
Q3 		$462K Buy
52,711
+14,000
+36% +$101K 0.02% 1169
2015
Q2 		$269K Buy
+38,711
New +$242K 0.01% 1665

Other funds holding SMED

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

GSA Capital Partners's SMED Position: Q1 2022 in Review

GSA Capital Partners sold out of Sharps Compliance Corp (SMED) in Q1 2022, closing a stake of 37,715 shares — an estimated $269K sold.

GSA Capital Partners first reported a position in SMED in Q2 2015 and held it in 13 quarters. The position peaked at $868K in Q4 2015. 80 funds tracked by Wall St. Rank hold SMED as of Q1 2022.

  • GSA Capital Partners reported no remaining Sharps Compliance Corp position as of Q1 2022 after selling out during the quarter.
  • GSA Capital Partners sold 37,715 Sharps Compliance Corp shares in Q1 2022, an estimated $269K.
  • GSA Capital Partners first reported a position in Sharps Compliance Corp in Q2 2015 and held it in 13 quarters.
  • GSA Capital Partners's Sharps Compliance Corp position peaked at $868K in Q4 2015.
  • 80 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.